160 related articles for article (PubMed ID: 8697636)
21. Monitoring antibody titers to recombinant Core-NS3 fusion polypeptide is useful for evaluating hepatitis C virus infection and responses to interferon-alpha therapy.
Park YM; Byun BH; Choi JY; Bae SH; Kim BS; So HS; Ryu WS
J Korean Med Sci; 1999 Apr; 14(2):165-70. PubMed ID: 10331562
[TBL] [Abstract][Full Text] [Related]
22. Mapping of serotype-specific, immunodominant epitopes in the NS-4 region of hepatitis C virus (HCV): use of type-specific peptides to serologically differentiate infections with HCV types 1, 2, and 3.
Simmonds P; Rose KA; Graham S; Chan SW; McOmish F; Dow BC; Follett EA; Yap PL; Marsden H
J Clin Microbiol; 1993 Jun; 31(6):1493-503. PubMed ID: 7686182
[TBL] [Abstract][Full Text] [Related]
23. Expression of the full-length HCV core subgenome from HCV gentoype-1a and genotype-3a and evaluation of the antigenicity of translational products.
Ansari MA; Irshad M; Agarwal SK; Chosdol K
Eur J Gastroenterol Hepatol; 2013 Jul; 25(7):806-13. PubMed ID: 23442416
[TBL] [Abstract][Full Text] [Related]
24. Reduced antibody reactivity to hepatitis C virus antigens in hemodialysis patients coinfected with hepatitis B virus.
Devesa M; Khudyakov YE; Capriles F; Blitz L; Fields HA; Liprandi F; Pujol FH
Clin Diagn Lab Immunol; 1997 Nov; 4(6):639-42. PubMed ID: 9384281
[TBL] [Abstract][Full Text] [Related]
25. [Spectrum of antibodies to HCV antigens in patients with different clinical patterns of chronic HCV infection].
Kruglov IV; Znoĭko OO; Ogienko OL; Ianina MV; Finogenova MP; Alekseenkova TI; Braginskiĭ DM; Kuzin SN; Sukhanova LL; Grinev AA; Selivanov NA; Doroshenko NV; Shibnev VA; Semiletov IuA
Vopr Virusol; 2002; 47(2):11-6. PubMed ID: 12046459
[TBL] [Abstract][Full Text] [Related]
26. Immunoreactivity of HCV/HBV epitopes displayed in an epitope-presenting system.
Chen Y; Xiong X; Liu X; Li J; Wen Y; Chen Y; Dai Q; Cao Z; Yu W
Mol Immunol; 2006 Feb; 43(5):436-42. PubMed ID: 16337486
[TBL] [Abstract][Full Text] [Related]
27. Identification of antigenic sites on three hepatitis C virus proteins using phage-displayed peptide libraries.
Pereboeva LA; Pereboev AV; Morris GE
J Med Virol; 1998 Oct; 56(2):105-11. PubMed ID: 9746064
[TBL] [Abstract][Full Text] [Related]
28. [Spontaneous HCV clearance: an association with gender, age, viral genotypes, infection transmission routes, and markers of HBV and HIV].
Fedorchenko SV; Martynovich TL; Liashok OV; Kariuk ZhA; Ianchenko VI
Ter Arkh; 2010; 82(3):52-6. PubMed ID: 20564924
[TBL] [Abstract][Full Text] [Related]
29. [Detection of antibodies to the nucleocapsid protein of Hepatitis C virus by immunoenzyme analysis using synthetic peptides of nucleocapsid N-terminal part].
Firsova TV; Alekseenkova TI; Shibnev VA; Froesner G; Semiletov IuA
Vopr Virusol; 2001; 46(2):21-4. PubMed ID: 11392965
[TBL] [Abstract][Full Text] [Related]
30. [Diagnostic significance of antibody detection to various hepatitis C virus antigens in patients with acute and chronic HCV-infection].
Iushchuk ND; Ogienko OL; Kruglov IV; Znoĭko OO; Braginskiĭ DM; Semiletov IuA; Finogenova MP; Alekseenkova TI; Ianina MV; Shibnev VA; Doroshenko NV
Ter Arkh; 2002; 74(4):18-22. PubMed ID: 12043232
[TBL] [Abstract][Full Text] [Related]
31. Primary, post-primary and non-specific immunoglobulin M responses in HCV infection.
Dustin LB; Charles ED
Antivir Ther; 2012; 17(7 Pt B):1449-52. PubMed ID: 23322600
[TBL] [Abstract][Full Text] [Related]
32. Generation and characterization of chimeric antibodies against NS3, NS4, NS5, and core antigens of hepatitis C virus.
Tu B; Ziemann RN; Tieman BC; Hawksworth DJ; Tyner J; Scheffel J; Pinkus MS; Brophy SE; Werneke JM; Gutierrez R; White M
Clin Vaccine Immunol; 2010 Jun; 17(6):1040-7. PubMed ID: 20427624
[TBL] [Abstract][Full Text] [Related]
33. Hepatitis C virus infection and cryoglobulinaemia.
Lunel F; Musset L
Forum (Genova); 1998; 8(1):95-103. PubMed ID: 9514994
[TBL] [Abstract][Full Text] [Related]
34. Improved reactivity of hepatitis C virus core protein epitopes in a conformational antigen-presenting system.
Buratti E; Di Michele M; Song P; Monti-Bragadin C; Scodeller EA; Baralle FE; Tisminetzky SG
Clin Diagn Lab Immunol; 1997 Mar; 4(2):117-21. PubMed ID: 9067642
[TBL] [Abstract][Full Text] [Related]
35. Humoral immune response and natural killer activity in patients with mixed cryoglobulinemia.
Gabrielli A; Sambo P; Zhang ZX; Candela M; Savoldi S; Manzin A; Clementi M; Amoroso A; Sallberg M; Danieli G
Clin Exp Rheumatol; 1995; 13 Suppl 13():S95-9. PubMed ID: 8730486
[TBL] [Abstract][Full Text] [Related]
36. Antibody response to core, envelope and nonstructural hepatitis C virus antigens: comparison of immunocompetent and immunosuppressed patients.
Lok AS; Chien D; Choo QL; Chan TM; Chiu EK; Cheng IK; Houghton M; Kuo G
Hepatology; 1993 Sep; 18(3):497-502. PubMed ID: 7689528
[TBL] [Abstract][Full Text] [Related]
37. Parvovirus B19 infection, hepatitis C virus infection, and mixed cryoglobulinaemia.
Cacoub P; Boukli N; Hausfater P; Garbarg-Chenon A; Ghillani P; Thibault V; Musset L; Huraux JM; Piette JC
Ann Rheum Dis; 1998 Jul; 57(7):422-4. PubMed ID: 9797569
[TBL] [Abstract][Full Text] [Related]
38. Comparison of prevalence of anti-hepatitis C virus antibodies in differing South American populations.
Robinson JW; Rosas M; Guzman F; Patarroyo ME; Moreno A
J Med Virol; 1996 Oct; 50(2):188-92. PubMed ID: 8915886
[TBL] [Abstract][Full Text] [Related]
39. The immunoreactivity profile of different HCV genotypes on immunoblot assay and its implications in the development of diagnostic assays.
Kanistanon D; Neelamek M; Dharakul T; Songsivilai S
Asian Pac J Allergy Immunol; 1997 Sep; 15(3):133-40. PubMed ID: 9438545
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of a multiple peptide assay for typing of antibodies to the hepatitis C virus: relation to genomic typing by the polymerase chain reaction.
Zhang ZX; Yun ZB; Chen M; Sönnerborg A; Sällberg M
J Med Virol; 1995 Jan; 45(1):50-5. PubMed ID: 7536231
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
